Search
Close this search box.

Phase-Appropriate CMC Development For Synthetic Peptides

Organization:
United States Pharmacopeial Convention
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
[email protected]
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
Bachem’s modular CMC development concept will be presented. The concept is based on experience with a wide range of customers (virtual to big Pharma) and represents Bachem’s best practice recommendations for the successful development of a robust…